Tag Archives: Trade War

Financial Daily Dose 3.23.2020 | Top Story: The Fallout of COVID-19 Continues

BY: Juvian Hernandez | March 23, 2020

The fallout of COVID-19 continues: “S&P 500 futures fell nearly 4%;” the yield on 10-year U.S. Treasury notes fell to 0.788%; Brent crude fell by 4.6%; the stimulus and fiscal relief package hit a roadblock in the Senate; and the US’s COVID-19 infections jumped 10x from just a week ago. – WSJ and Bloomberg and NYTimes For more on oil … Continue reading

Financial Daily Dose 1.22.2020 | Top Story: Boeing Again Delays Return of 737Max to the Skies

BY: Michael D. Reif | January 22, 2020

Boeing has again pushed back the return of its flawed 737Max model, revealing yesterday that it doesn’t expect regulators to sign-off on their return to the air until at least summer – NYTimes and WSJ and Bloomberg and MarketWatch Brazilian prosecutors have charged former Vale SA CEO Fabio Schvartsman and ten others with homicide “in … Continue reading

Financial Daily Dose 1.7.2020 | Top Story: Facebook Ban of “Deepfakes”

BY: Juvian Hernandez | January 7, 2020

Facebook wages a war on misinformation. On Monday, Facebook announced it will start removing videos altered by artificial intelligence that are likely to mislead people into thinking that a subject of the video made statements they never actually stated. The policy will not apply to parody and satire. New York Times – Bloomberg and WSJ … Continue reading

Financial Daily Dose 12.03.2019 | Top Story: US Threatens Tariffs on French Goods Over New Digital Services Tax

BY: Michael D. Reif | December 3, 2019

Because who wants a nice quiet December, right? Yesterday, the U.S. opened yet another trade war front by proposing retaliatory tariffs of up to 100% on a wide range of French imports after announcing that “it found France’s newly enacted digital service tax to discriminate against U.S. companies.” The proposed levies wouldn’t take effect until … Continue reading

Financial Daily Dose 10.9.2019 | Top Story: Chair Powell says Fed will Expand its Treasury Securities Holdings

BY: Michael D. Reif | October 9, 2019

Fed Chair Powell, speaking at an economics conference in Denver yesterday, made news by indicating that the central bank would “once again begin expanding its portfolio of government-backed securities”—a shift in policy hastened by recent repo market shortages requiring Fed intervention – NYTimes and WSJ and Bloomberg and MarketWatch and Law360 A Philly jury has … Continue reading

Financial Daily Dose 10.7.2019 | Top Story: Talks Between GM and UAW Falter as Strike Hits Fourth Week

BY: Michael D. Reif | October 7, 2019

Talks between General Motors and the striking UAW broke down yesterday, threatening the progress the two sides “appeared to make in recent days,” a troubling sign as the strike heads into its 4th week – NYTimes and WSJ and Bloomberg Things at Nissan are getting worse—much worse—before getting better in the wake of the Carlos … Continue reading

Financial Daily Dose 10.2.2019 | Top Story: Johnson & Johnson Pays Out $20 Million to Avoid First Opioid Trial

BY: Michael D. Reif | October 2, 2019

Johnson & Johnson doled out $20 million to two Ohio counties rather than go through with its first federal opioid-related trial. The money is rather small potatoes for J&J, but it marks the “first time . . . the world’s largest maker of healthcare products agreed to settle an opioid-related lawsuit” – Bloomberg and Law360 … Continue reading

Financial Daily Dose 8.30.2019 | Top Story: E-cig Company Juul Faces Federal Probes into Marketing and Health Concerns

BY: Michael D. Reif | August 30, 2019

The FTC has opened a probe into e-cigarette maker Juul’s marketing practices, including allegations that the company “used influencers and other marketing to appeal to minors” – WSJ The inquiry only adds to Juul’s federal agency concerns – Bloomberg Saudi Aramco unveiled plans on Thursday for a two-stage IPO that with debut on the Saudi … Continue reading

Financial Daily Dose 8.27.2019 | Top Story: OK Judge Hits Johnson & Johnson With $572 Million Fine in Opioid Trial

BY: Michael D. Reif | August 27, 2019

A bad day for J&J in Oklahoma at the close of the state’s trial against Johnson & Johnson means that the company’s on the hook for upwards of $572 million for its role in the opioid crisis that’s decimated swaths of the state. The trial was the first against an opioid manufacturer and bodes ill … Continue reading

Financial Daily Dose 8.26.2019 | Top Story: Amgen to Pay More Than $13 Billion for Otezla

BY: Michael D. Reif | August 26, 2019

Amgen will pay $13.4 billion in cash to buy psoriasis treatment Otezla, a deal that will “pave the way for Bristol-Myers Squibb to complete its acquisition of Celgene” by addressing “regulatory concerns over their union” – WSJ Fed Chair Powell seemed to hit just about all the right notes in Jackson Hole on Friday (with … Continue reading